Literature DB >> 18020099

Angiotensin-converting enzyme expression of the lymphoma-associated macrophages in the lymph nodes of Hodgkin's disease.

Ebru Koca1, Ibrahim C Haznedaroglu, Aysegul Uner, Nilgün Sayinalp, Arzu E Saglam, Hakan Goker, Osman I Ozcebe.   

Abstract

OBJECTIVE: Angiotensin-converting enzyme (ACE) is involved in the control of cellular proliferation. Tumor-associated macrophages promote lymphoma pathogenesis via affecting tumor cell growth and associated survival factors. We assessed ACE expression in the neoplastic lymph node microenvironment of Hodgkin's lymphoma (HL), particularly in macrophages and in nonneoplastic lymphoid tissue.
METHODS: Paraffin sections of the lymph nodes from randomly selected 20 HL cases with nodular sclerosing and 20 mixed cellular types were included into the study. Five normal tonsils and five lymph nodes showing reactive lymphoid hyperplasia were used as controls. Immunohistochemistry of lymph node biopsies had been performed with monoclonal antibody against human ACE. Sections were evaluated by two pathologists.
RESULTS: ACE-expressing histiocytes were observed in lymph nodes of HL. ACE staining was also observed in the vascular endothelium in all the tissues evaluated. Neoplastic lymphoid tissues and control tissues did not express ACE.
CONCLUSION: ACE expression of the lymphoma-associated macrophages in the lymph nodes of HL may represent the point of cross-talk between renin-angiotensin system (RAS) and lymphomagenesis. ACE could serve in the pathobiological function of the tissue-based macrophages in tumorigenesis of HL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18020099      PMCID: PMC2574316     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  21 in total

1.  Micro-environmental factors in the survival of human B-lymphoma cells.

Authors:  J M Levens; J Gordon; C D Gregory
Journal:  Cell Death Differ       Date:  2000-01       Impact factor: 15.828

2.  Over-expression of angiotensin-converting enzyme (CD 143) on leukemic blasts as a clue for the activated local bone marrow RAS in AML.

Authors:  Salih Aksu; Yavuz Beyazit; Ibrahim C Haznedaroglu; Hande Canpinar; Murat Kekilli; Aysegul Uner; Nilgün Sayinalp; Yahya Büyükaşik; Hakan Goker; Osman I Ozcebe
Journal:  Leuk Lymphoma       Date:  2006-05

Review 3.  Views of the renin-angiotensin system: brilling, mimsy, and slithy tove.

Authors:  Kenneth E Bernstein
Journal:  Hypertension       Date:  2005-12-19       Impact factor: 10.190

Review 4.  Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system.

Authors:  Ibrahim C Haznedaroglu; M Akif Oztürk
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

5.  The presence of STAT1-positive tumor-associated macrophages and their relation to outcome in patients with follicular lymphoma.

Authors:  Tomás Alvaro; Marylène Lejeune; Francisca I Camacho; Ma Teresa Salvadó; Lydia Sánchez; Juan F García; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons; Carmen Bellas; Miguel A Piris
Journal:  Haematologica       Date:  2006-12       Impact factor: 9.941

6.  Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Authors:  Tomás Alvaro; Marylène Lejeune; Maria-Teresa Salvadó; Carlos Lopez; Joaquín Jaén; Ramón Bosch; Lluis E Pons
Journal:  J Clin Oncol       Date:  2006-12-01       Impact factor: 44.544

7.  Overexpression of the local bone marrow renin-angiotensin system in acute myeloid leukemia.

Authors:  Yavuz Beyazit; Salih Aksu; Ibrahim C Haznedaroglu; Murat Kekilli; Muge Misirlioglu; Serdar Tuncer; Jale Karakaya; Ebru Koca; Yahya Buyukasik; Nilgun Sayinalp; Hakan Goker
Journal:  J Natl Med Assoc       Date:  2007-01       Impact factor: 1.798

8.  I/D ACE gene polymorphism in survival of leukemia patients -- hypothesis and pilot study.

Authors:  Dobroslav Hajek; Miroslav Tomiska; Eva Krahulcova; Miloslav Druckmuller; Michaela Florianova; Lydie Izakovicova-Holla; Jiri Vacha
Journal:  Med Hypotheses       Date:  2003-07       Impact factor: 1.538

9.  Circulating and local bone marrow renin-angiotensin system in leukemic hematopoiesis: preliminary evidences.

Authors:  Hüseyin Abali; Ibrahim C Haznedaroglu; Hakan Goker; Ismail Celik; Düzgün Ozatli; Zehra Koray; Meltem Caglar
Journal:  Hematology       Date:  2002-04       Impact factor: 2.269

10.  The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer.

Authors:  Christoph Röcken; Friedrich-Wilhelm Röhl; Eva Diebler; Uwe Lendeckel; Matthias Pross; Stacy Carl-McGrath; Matthias P A Ebert
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

View more
  4 in total

1.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

2.  Local bone marrow Renin-Angiotensin system and atherosclerosis.

Authors:  Yavuz Beyazit; Tugrul Purnak; Gulay Sain Guven; Ibrahim C Haznedaroglu
Journal:  Cardiol Res Pract       Date:  2010-12-22       Impact factor: 1.866

3.  COVID-19, Renin-Angiotensin System, and Hematopoiesis

Authors:  Rafiye Çiftçiler; İbrahim C. Haznedaroğlu
Journal:  Turk J Haematol       Date:  2020-05-12       Impact factor: 1.831

4.  Angiotensin II enhances the proliferation of Natural Killer/T-cell lymphoma cells via activating PI3K/Akt signaling pathway.

Authors:  Gui-Hua Zhang; Fa-An Miao; Jin-Ge Xu; Yan Zhang
Journal:  Biosci Rep       Date:  2020-10-30       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.